Rollover Study to Provide Continued Access to TT-00420 (Tinengotinib) for Subjects With Advanced Solid Tumors
Clinical trial NCT06370013 · AVAILABLE
Trial details
- NCT number
- NCT06370013
- Sponsor
- TransThera Sciences (Nanjing), Inc.
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.